A real world evaluation of the long-term efficacy of strategies to prevent chronic Pseudomonas aeruginosa pulmonary infection in children with cystic fibrosis

Background: Children with cystic fibrosis (CF) are susceptible to chronic Pseudomonas aeruginosa (PA) infection. Early eradication of PA has proven short-term efficacy. No studies have evaluated the long- term impact of early eradication for CF patients, particularly those diagnosed by newborn scree...

Full description

Bibliographic Details
Main Authors: Fargol Mostofian, Jamal Alkadri, Kenneth Tang, Nisha Thampi, Dhenuka Radhakrishnan
Format: Article
Language:English
Published: Elsevier 2019-08-01
Series:International Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971219302334
_version_ 1818902436433100800
author Fargol Mostofian
Jamal Alkadri
Kenneth Tang
Nisha Thampi
Dhenuka Radhakrishnan
author_facet Fargol Mostofian
Jamal Alkadri
Kenneth Tang
Nisha Thampi
Dhenuka Radhakrishnan
author_sort Fargol Mostofian
collection DOAJ
description Background: Children with cystic fibrosis (CF) are susceptible to chronic Pseudomonas aeruginosa (PA) infection. Early eradication of PA has proven short-term efficacy. No studies have evaluated the long- term impact of early eradication for CF patients, particularly those diagnosed by newborn screening (NBS). Our objective was to quantify the long-term impact of early PA eradication on the risk of chronic PA infection in children (0–18 years old) with CF prior to and following the introduction of a province-wide NBS program. Methods: This 20-year retrospective cohort study compared 94 patients eligible for treatment with inhaled tobramycin at first PA isolation (“recent cohort”) with 27 historical controls (“historical cohort”). Results: A smaller proportion of patients in the recent cohort developed chronic PA (24% versus 78%; P < 0.001); the adjusted risk of chronic infection was 2.90 (95%CI 1.47, 5.76; P = 0.002) in the historical vs recent cohort. However, NBS was not independently associated with the risk of chronic PA infection after its introduction. Conclusions: Early eradication of PA, irrespective of early diagnosis, is associated with reduced risk of chronic PA. However, concomitant improvements in medical care since the introduction of early eradication protocols may have contributed to these long-term observed benefits. Keywords: Child, Cystic fibrosis, Pseudomonas, Antibacterial agents, Early diagnosis
first_indexed 2024-12-19T20:35:37Z
format Article
id doaj.art-3cd5ed77f8504f239b29c961598c3ffe
institution Directory Open Access Journal
issn 1201-9712
language English
last_indexed 2024-12-19T20:35:37Z
publishDate 2019-08-01
publisher Elsevier
record_format Article
series International Journal of Infectious Diseases
spelling doaj.art-3cd5ed77f8504f239b29c961598c3ffe2022-12-21T20:06:33ZengElsevierInternational Journal of Infectious Diseases1201-97122019-08-01859297A real world evaluation of the long-term efficacy of strategies to prevent chronic Pseudomonas aeruginosa pulmonary infection in children with cystic fibrosisFargol Mostofian0Jamal Alkadri1Kenneth Tang2Nisha Thampi3Dhenuka Radhakrishnan4Faculty of Medicine, University of Ottawa, Ottawa, Ontario, CanadaFaculty of Medicine, University of Ottawa, Ottawa, Ontario, CanadaChildren’s Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, CanadaFaculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, CanadaFaculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada; Corresponding author at: Children’s Hospital of Eastern Ontario, 401 Smyth Road, Ottawa, Ontario, Canada.Background: Children with cystic fibrosis (CF) are susceptible to chronic Pseudomonas aeruginosa (PA) infection. Early eradication of PA has proven short-term efficacy. No studies have evaluated the long- term impact of early eradication for CF patients, particularly those diagnosed by newborn screening (NBS). Our objective was to quantify the long-term impact of early PA eradication on the risk of chronic PA infection in children (0–18 years old) with CF prior to and following the introduction of a province-wide NBS program. Methods: This 20-year retrospective cohort study compared 94 patients eligible for treatment with inhaled tobramycin at first PA isolation (“recent cohort”) with 27 historical controls (“historical cohort”). Results: A smaller proportion of patients in the recent cohort developed chronic PA (24% versus 78%; P < 0.001); the adjusted risk of chronic infection was 2.90 (95%CI 1.47, 5.76; P = 0.002) in the historical vs recent cohort. However, NBS was not independently associated with the risk of chronic PA infection after its introduction. Conclusions: Early eradication of PA, irrespective of early diagnosis, is associated with reduced risk of chronic PA. However, concomitant improvements in medical care since the introduction of early eradication protocols may have contributed to these long-term observed benefits. Keywords: Child, Cystic fibrosis, Pseudomonas, Antibacterial agents, Early diagnosishttp://www.sciencedirect.com/science/article/pii/S1201971219302334
spellingShingle Fargol Mostofian
Jamal Alkadri
Kenneth Tang
Nisha Thampi
Dhenuka Radhakrishnan
A real world evaluation of the long-term efficacy of strategies to prevent chronic Pseudomonas aeruginosa pulmonary infection in children with cystic fibrosis
International Journal of Infectious Diseases
title A real world evaluation of the long-term efficacy of strategies to prevent chronic Pseudomonas aeruginosa pulmonary infection in children with cystic fibrosis
title_full A real world evaluation of the long-term efficacy of strategies to prevent chronic Pseudomonas aeruginosa pulmonary infection in children with cystic fibrosis
title_fullStr A real world evaluation of the long-term efficacy of strategies to prevent chronic Pseudomonas aeruginosa pulmonary infection in children with cystic fibrosis
title_full_unstemmed A real world evaluation of the long-term efficacy of strategies to prevent chronic Pseudomonas aeruginosa pulmonary infection in children with cystic fibrosis
title_short A real world evaluation of the long-term efficacy of strategies to prevent chronic Pseudomonas aeruginosa pulmonary infection in children with cystic fibrosis
title_sort real world evaluation of the long term efficacy of strategies to prevent chronic pseudomonas aeruginosa pulmonary infection in children with cystic fibrosis
url http://www.sciencedirect.com/science/article/pii/S1201971219302334
work_keys_str_mv AT fargolmostofian arealworldevaluationofthelongtermefficacyofstrategiestopreventchronicpseudomonasaeruginosapulmonaryinfectioninchildrenwithcysticfibrosis
AT jamalalkadri arealworldevaluationofthelongtermefficacyofstrategiestopreventchronicpseudomonasaeruginosapulmonaryinfectioninchildrenwithcysticfibrosis
AT kennethtang arealworldevaluationofthelongtermefficacyofstrategiestopreventchronicpseudomonasaeruginosapulmonaryinfectioninchildrenwithcysticfibrosis
AT nishathampi arealworldevaluationofthelongtermefficacyofstrategiestopreventchronicpseudomonasaeruginosapulmonaryinfectioninchildrenwithcysticfibrosis
AT dhenukaradhakrishnan arealworldevaluationofthelongtermefficacyofstrategiestopreventchronicpseudomonasaeruginosapulmonaryinfectioninchildrenwithcysticfibrosis
AT fargolmostofian realworldevaluationofthelongtermefficacyofstrategiestopreventchronicpseudomonasaeruginosapulmonaryinfectioninchildrenwithcysticfibrosis
AT jamalalkadri realworldevaluationofthelongtermefficacyofstrategiestopreventchronicpseudomonasaeruginosapulmonaryinfectioninchildrenwithcysticfibrosis
AT kennethtang realworldevaluationofthelongtermefficacyofstrategiestopreventchronicpseudomonasaeruginosapulmonaryinfectioninchildrenwithcysticfibrosis
AT nishathampi realworldevaluationofthelongtermefficacyofstrategiestopreventchronicpseudomonasaeruginosapulmonaryinfectioninchildrenwithcysticfibrosis
AT dhenukaradhakrishnan realworldevaluationofthelongtermefficacyofstrategiestopreventchronicpseudomonasaeruginosapulmonaryinfectioninchildrenwithcysticfibrosis